Objective
The safety and efficacy of bone marrow transplantation using donors other than human leucocyte antigen (HLA) identical siblings was investigated. The results of analyses conducted are preliminary. Nonetheless a substantial proportion of leukemia patients were disease free, alive and well following transplantation of HLA incompatible bone marrow donated by family members.
Fields of science
Topic(s)
Data not availableCall for proposal
Data not availableFunding Scheme
CSC - Cost-sharing contractsCoordinator
8701 MILWAUKEE
United States